Imugene Limited (ASX:IMU) Three Complete Responses in Azer-Cel Phase 1b Trial

(3:51)

ASX Small and Mid-Cap Conference March 2024 | Imugene Ltd (ASX:IMU)

(20:44)

Imugene MAST trial delivers two-year complete response in bile tract cancer patient

(4:54)

How Imugene is Turning Viruses into Cancer-Fighting Heroes!

(32:27)

Imugene CEO And COO Speak With JustStocks Video After Promising Results In Blood Cancer Trial

(7:17)

Developing Cancer Cures through the ASX | Going Public w Leslie Chong \u0026 Paul Hopper

(53:26)

Groundbreaking cancer trial: Imugene’s CF33 advances in clinical success

(16:2)

Imugene’s $20 million boost and cancer trial updates

(7:42)

Imugene (ASX:IMU) | JMM \u0026 éthica Capital Innovation Interview \\ May 2024

(5:4)

Developing Cancer Cures through the ASX | Going Public w Leslie Chong \u0026 Paul Hopper

(53:26)

Imugene expands CAR T-Cell and Oncolytic Virotherapy trials in Australia and the US

(5:25)

Leslie Chong Discusses Imugene's Strategic Partnership with Kincell Bio | AusBiz Interview

(6:37)

Imugene MAST trial delivers two-year complete response in bile tract cancer patient

(4:54)

Interview With The CF33 Oncolytic Virus Inventor - Imugene (IMU)

(20:11)

ASX Stocks to Buy and Hold Forever: Your Ultimate Long-Term Investment

(22:31)

Imugene (ASX:IMU) | Webinar with Leslie Chong | 07/11/24

(26:56)

The stock of the day is Imugene (IMU)

(7:48)

Imugene expands CAR T-Cell and Oncolytic Virotherapy trials in Australia and the US

(5:25)

ASX CEO Connect March 2023 Imugene Limited (ASX: IMU)

(18:10)

Imugene (ASX:IMU) | JMM \u0026 éthica Capital Innovation \u0026 Investment Insights | May 2024

(15:6)

ASX - CEO Connect March 2022 - Imugene Limited (ASX IMU)

(11:43)

Imugene (ASX:IMU) doses first patient in IV arm of Phase 1 onCARlytics trial targeting solid cancers

(4:14)

Imugene’s ASX IMU azer cel CAR T therapy trial shows encouraging results in blood cancer

(1:43)

Imugene Interview with CEO/MD Leslie Chong ASX:IMU

(10:5)

Imugene Limited (ASX: IMU) Emergence 2024: Presentation by Leslie Chong, Managing Director and CEO

(7:40)

Imugene’s $20 million boost and cancer trial updates

(7:42)

Just the Facts: Imugene receives Orphan Drug Designation for VAXINIA from FDA

(1:58)

Biotech Unlocked - IMUGENE ASX:IMU

(18:36)

Infinity Series with Imugene Chairman Paul Hopper ASX: IMU

(29:41)

Imugene (ASX:IMU) | JMM \u0026 éthica Capital Innovation \u0026 Investment Insights | May 2024

(15:6)